Pharsight

Epinephrine patents expiration

EPINEPHRINE Litigations

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US10039728 BPI LABS More potent and less toxic formulations of epinephrine and methods of medical use
Aug, 2034

(10 years from now)

US10004700 BPI LABS More potent and less toxic formulations of epinephrine and methods of medical use
Aug, 2034

(10 years from now)

US9283197 BPI LABS More potent and less toxic formulations of epinephrine and methods of medical use
Aug, 2034

(10 years from now)

Epinephrine is owned by Bpi Labs.

Epinephrine contains Epinephrine.

Epinephrine has a total of 3 drug patents out of which 0 drug patents have expired.

Epinephrine was authorised for market use on 04 March, 2024.

Epinephrine is available in solution;intravenous, intraocular, intramuscular, subcutaneous dosage forms.

Epinephrine can be used as induction and maintenance of mydriasis during intraocular surgery, increasing mean arterial blood pressure in adult patients with hypotension associated with septic shock, emergency treatment of allergic reactions (type 1), including anaphylaxis; a method of treating allergic reaction, anaphylaxis, anaphylactic shock, or combination thereof by an injection of at least one dosage of the injectable liquid pharmaceutical.

The generics of Epinephrine are possible to be released after 15 August, 2034.

Stay ahead of others in designing the generic launch strategy of these 5 blockbuster drugs expiring in next 5 years.

Get the exclusive patent insights now. Don't be the last to know.

Drugs and Companies using EPINEPHRINE ingredient

Market Authorisation Date:

04 March, 2024

Treatment:

Increasing mean arterial blood pressure in adult patients with hypotension associated with septic shock; Emergency treatment of allergic reactions (type 1), including anaphylaxis; A method of treating...

Dosage:

SOLUTION;INTRAVENOUS, INTRAOCULAR, INTRAMUSCULAR, SUBCUTANEOUS

How can I launch a generic of EPINEPHRINE before its drug patent expiration?

More Information on Dosage

EPINEPHRINE family patents

Family Patents